B. Riley equity line of credit
Company: Core Scientific
The claim, verbatim
Company has right to sell up to $100 million of common stock to B. Riley Principal Capital II
Source (primary)
Core Scientific 424B3 filed 2022-10-27 (SEC EDGAR, sec_filing)
View cached copy (2026-09-13)Live source ↗
Quote: “the Company has the right to sell to B. Riley up to $100,000,000 of shares of the Company's common stock”
How we checked this
This claim has not yet been checked assertion-by-assertion against its source. It carries a cited source and quote, but the deeper check has not run. When it does, the result appears here whatever it says.
Additional evidence
confirms Core Scientific 424B3 filed 2022-10-27
Quote: “the Company has the right to sell to B. Riley up to $100,000,000 of shares of the Company's common stock”